Global Nuclear Medicine Diagnostic Equipment Market Growth 2023-2029

Global Nuclear Medicine Diagnostic Equipment Market Growth 2023-2029

The global Nuclear Medicine Diagnostic Equipment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

In terms of the popularity and advancement of the product, SPECT was used clinically before PET, and the penetration rate is higher than that of PET, but the imaging effect of PET is clearer, the radiation damage to the human body is less, and it is more advanced than SPECT. In recent years, the development of PET The market is also growing faster. PET equipment is usually fused with CT and MRI to form PET/CT and PET/MR, and SPECT equipment is usually fused with CT to form SPECT/CT. Separate PET and SPECT equipment have gradually withdrawn from the market.



Currently commonly used medical imaging methods include X-ray imaging, ultrasound imaging, CT, nuclear magnetic resonance MRI, SPECT/CT, PET/CT and PET/MR.

Nuclear medicine diagnosis mainly refers to nuclide imaging diagnosis, which can be divided into single photon emission computed tomography (SPECT) and positron emission computed tomography (PET) according to the different ways and types of radioactive elements used to emit gamma photons. Its principle is to inject single-photon/positron radioactive drugs into the human body, and then use SPECT or PET equipment to image the distribution of radionuclides, so as to analyze the function or metabolism of various organs to diagnose diseases. .

LPI (LP Information)' newest research report, the “Nuclear Medicine Diagnostic Equipment Industry Forecast” looks at past sales and reviews total world Nuclear Medicine Diagnostic Equipment sales in 2022, providing a comprehensive analysis by region and market sector of projected Nuclear Medicine Diagnostic Equipment sales for 2023 through 2029. With Nuclear Medicine Diagnostic Equipment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nuclear Medicine Diagnostic Equipment industry.

This Insight Report provides a comprehensive analysis of the global Nuclear Medicine Diagnostic Equipment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nuclear Medicine Diagnostic Equipment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Nuclear Medicine Diagnostic Equipment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nuclear Medicine Diagnostic Equipment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nuclear Medicine Diagnostic Equipment.

This report presents a comprehensive overview, market shares, and growth opportunities of Nuclear Medicine Diagnostic Equipment market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
SPECT
PET

Segmentation by application
Tumor Imaging
Bone Marrow Imaging
Endocrine System Imaging
Urinary System Imaging
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
GE HealthCare
Siemens Healthineers
Philips
Mediso Medical Imaging Systems
Digirad
Toshiba
Compañía Mexicana
SurgicEye
CMR Naviscan
DDD-Diagnostic
Positron
TeraRecon
Neusoft Group
United Imaging
MinFound Medical
SinoUnion Healthcare
Top Grade Healthcare

Key Questions Addressed in this Report

What is the 10-year outlook for the global Nuclear Medicine Diagnostic Equipment market?

What factors are driving Nuclear Medicine Diagnostic Equipment market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Nuclear Medicine Diagnostic Equipment market opportunities vary by end market size?

How does Nuclear Medicine Diagnostic Equipment break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.